| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | 1 | — | — | — |
| Sell | — | — | — | — | — | — | — | 1 | — | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2026 | 5.85 |
—
—
—
—
|
| 2025 | 5.46 |
—
—
—
—
|
| 2024 | 5.10 |
—
—
—
—
|
| 2023 | 4.76 |
—
—
—
—
|
| 2022 | 4.44 |
—
—
—
—
|
| 2021 | 4.14 |
—
—
—
—
|
| 2020 | 3.86 |
—
—
—
—
—
|
| 2019 | 3.60 |
—
—
—
—
|
| 2018 | 4.19 |
—
—
—
—
—
|
| 2017 | 3.13 |
—
—
—
—
|
| 2016 | 2.19 |
—
—
—
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 144.06 | 298.40 | 345.87 | 282.90 |
| Receivables | 625.34 | 707.06 | 735.59 | 753.25 |
| Inventory | — | — | — | — |
| Other | — | — | — | — |
| 769.39 | 1,005.46 | 1,081.46 | 1,036.15 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 529.33 | 598.34 | 626.02 | 662.97 |
| ST’ Debt | — | — | — | — |
| Other | — | — | — | — |
| 529.33 | 598.34 | 626.02 | 662.97 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 1,011.91 | 1,089.80 | — | — |
—
|
| ’25 | 989.40 | 1,060.10 | 1,066.74 | 951.02 |
4,067.26
|
| ’24 | 880.70 | 990.44 | 999.89 | 924.09 |
3,795.12
|
| ’23 | 752.47 | 839.87 | 858.94 | 817.67 |
3,268.94
|
| ’22 | 672.11 | 726.14 | 741.24 | 700.63 |
2,840.12
|
| ’21 | 630.18 | 680.03 | 687.84 | 635.93 |
2,633.98
|
| ’20 | 616.74 | 657.02 | 653.48 | 609.25 |
2,536.49
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 91.89 | 214.92 | — | — |
—
|
| ’25 | 118.12 | 177.58 | 219.41 | 171.56 |
686.66
|
| ’24 | 87.19 | 131.43 | 199.17 | 193.46 |
611.25
|
| ’23 | 48.03 | 131.98 | 52.76 | 148.44 |
381.21
|
| ’22 | 23.55 | 82.72 | 131.83 | 128.04 |
366.15
|
| ’21 | 33.48 | 94.24 | 136.32 | 138.76 |
402.79
|
| ’20 | 20.08 | 107.21 | 107.20 | 108.12 |
342.60
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 54.48 | 173.40 | — | — |
—
|
| ’25 | 88.44 | 157.32 | 184.41 | 140.79 |
570.97
|
| ’24 | 64.75 | 103.39 | 171.46 | 146.82 |
486.40
|
| ’23 | 28.89 | 106.12 | 25.66 | 127.89 |
288.56
|
| ’22 | 8.13 | 70.28 | 109.08 | 111.73 |
299.21
|
| ’21 | 22.34 | 77.19 | 126.42 | 28.05 |
253.99
|
| ’20 | (1.01) | 90.87 | 92.33 | 104.89 |
287.08
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 2.88 | 3.45 | — | — |
—
|
| ’25 | 2.65 | 3.34 | 3.50 | 1.21 |
10.69
|
| ’24 | 2.38 | 3.13 | 3.06 | 2.91 |
11.48
|
| ’23 | 1.65 | 2.25 | 2.51 | 2.12 |
8.53
|
| ’22 | 1.31 | 1.53 | 1.61 | 1.25 |
5.71
|
| ’21 | 1.41 | 1.51 | 1.72 | 1.05 |
5.69
|
| ’20 | 1.13 | 1.57 | 1.71 | 1.20 |
5.61
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 158.46 | 199.49 | 321.05 | 273.59 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 286.50 | 336.05 | 547.00 | 456.93 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6,038 | 6,556 | 6,801 | 6,667 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.47 | 0.50 | 0.56 | 0.61 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,840.12 | 3,268.94 | 3,795.12 | 4,067.26 | ‡‡‡‡‡ | — | — |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 13.25% | 15.92% | 17.82% | 17.63% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 376.45 | 561.94 | 757.28 | 710.60 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 13.25% | 17.19% | 19.95% | 17.47% | ‡‡‡ | — | — |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 298.57 | 446.06 | 600.31 | 559.34 | ‡‡‡‡‡ | — | — |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 51.72 | 53.59 | 63.91 | 76.78 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 61.49 | 70.77 | 82.16 | 88.05 | ‡‡‡‡‡ | — | — |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | 6.41 | 9.58 | 12.89 | 12.01 | ‡‡‡‡‡ | — | — |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7.93 | 8.25 | 13.23 | 14.87 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1.45) | (2.01) | (2.70) | (2.50) | ‡‡‡ | — | — |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6.48 | 6.25 | 10.53 | 12.36 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 31.36 | 36.00 | 43.02 | 49.43 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 46.19 | 46.19 | 46.19 | 46.19 | ‡‡‡‡‡ | — | — |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 38.14 | 35.01 | 32.01 | 23.87 | ‡‡‡‡ | — | — |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.98 | 4.73 | 5.02 | 3.26 | ‡‡‡ | — | — |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7.80 | 9.31 | 9.58 | 5.80 | ‡‡‡ | — | — |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.97 | 4.73 | 4.97 | 3.20 | ‡‡‡ | — | — |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 37.70 | 53.58 | 38.80 | 22.81 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 366.15 | 381.21 | 611.25 | 686.66 | ‡‡‡ | — | — |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (66.94) | (92.65) | (124.84) | (115.69) | — | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 299.21 | 288.56 | 486.40 | 570.97 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 201.08 | 240.06 | 407.12 | 455.44 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | — | — | — | — | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (142.09) | (144.05) | (298.40) | (345.87) | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,448.41 | 1,662.84 | 1,987.26 | 2,283.37 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 13.32% | 18.94% | 22.40% | 17.92% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 18.00% | 21.41% | 25.03% | 23.13% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 21.40% | 28.67% | 32.89% | 26.19% | — | — | — |
ROE
|
Erie Indemnity Company (ERIE) has delivered explosive growth as the attorney-in-fact for the Erie Insurance Exchange, with revenue surging 138% from $1.60 billion in 2016 to $3.80 billion in 2024, even powering through the COVID-19 disruptions with a 2.5% gain in 2020. This reflects a sticky policyholder base, operational efficiency—revenue per employee up 75% despite staff growth—and scaling in a hardening insurance market fueled by premium hikes and higher volumes. Free cash flow per share doubled to $10.53, underscoring ERIE’s ability to generate cash while keeping costs in check.
Profitability is soaring, with EPS nearly tripling to $12.89, ROE hitting 32.9%, and margins rebounding amid better pricing and loss controls post-natural disasters. The balance sheet is rock-solid, boasting $1.99 billion in equity (up 143%), substantial net cash, and ample liquidity. Despite a recent 15% stock dip from 2024 lows amid market rotations, revenue per share has outpaced price gains, trading at reasonable multiples like 32x PE and hinting at undervaluation versus historic trends.
Looking ahead, analysts forecast 8% revenue growth to $4.09 billion in 2025 and steady EPS expansion to $14.01 by 2026, powered by digital innovations, geographic push, and climate-resilient underwriting in a massive P&C market. With fundamentals screaming higher amid lagging targets, ERIE offers 50%+ upside potential for patient investors—don’t miss this under-the-radar powerhouse.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.